2 Top Managers on Secular Change and the Market
T. Rowe Price's David Giroux and Wellington Management's Jean Hynes talk value investing, innovation in healthcare, and where they're finding opportunity.
T. Rowe Price's David Giroux and Wellington Management's Jean Hynes talk value investing, innovation in healthcare, and where they're finding opportunity.
A recurring theme at the conference was: Will value investing ever rebound? Is a reversion to the mean forthcoming or has the market fundamentally changed during the past decade?
Morningstar's director of equity strategies Katie Reichart posed those questions--and many others--to two fund managers who've proved adept at valuing companies relative to their growth prospects: Giroux, who manages Gold-rated T. Rowe Price Capital Appreciation (PRWCX), and Hynes, who leads Gold-rated Vanguard Health Care (VGHCX).
Susan Dziubinski does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.